🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This is an open label, multi-center, single arm study to evaluate the effic...
Status
Unknown
Location
Anhui province hospital
Start Date
2022-07-25
Trial ID
NCT05407519
Treatments Being Tested
This study will explore the efficacy and safety of tislelizumab (PD1 inhibi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05350917
Treatments Being Tested
To explore the efficiency and safety of TP chemotherapy, tislelizumab, comb...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2022-09-12
Trial ID
NCT05516589
Treatments Being Tested
This was an open label, multicenter, Phase 2 study designed to assess the e...
Status
Completed
Location
Fujian Cancer Hospital
Start Date
2021-04-19
Trial ID
NCT04716634
Treatments Being Tested
Background: Ablation is important radical treatment in hepatocellular carci...
Status
Unknown
Location
302 Hospital
Start Date
2021-12-22
Trial ID
NCT06059885
Treatments Being Tested
The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Status
Unknown
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2022-01-20
Trial ID
NCT05717738
To estimate the safety and efficacy of hepatic artery infusion chemotherapy...
Status
Unknown
Location
Eastern Hepatobiliary Surgery Hospital
Start Date
2024-03
Trial ID
NCT06210334
Treatments Being Tested
The purpose of this study is to explore the efficiency and safety of anti-P...
Status
Completed
Location
Xingchen Peng
Start Date
2022-09-19
Trial ID
NCT05517330
Treatments Being Tested